Why DxNA
A significant challenge for government agencies, medical and veterinary professionals, the biotechnology industry and the scientific community is the cumbersome and protracted process of disease detection and diagnosis essential to timely clinical and tactical decision making. In addition, transportation of samples to large, centralized laboratories creates issues with sample degradation, contamination, cost, and delays.
DxNA created the GeneSTAT system to address the unmet need for low throughput point of care testing. The patented cartridge is sealed after the sample vessel is attached. The PCR mixture is preformulated and lyophilized and can be stored safely at ambient temperatures for over a year. The unique RFID tag on the cartridge is read by the analyzer, instantly directing the correct parameters of the PCR test. The GeneSTAT analyzer is light, rugged, and can be transported. The result? GeneSTAT delivers results as accurate as a complex and expensive lab based system, where the sample is collected. A true point of care system.
Drawbacks of DxNA’s competitors:
- Commercial systems purported to be portable are too bulky for convenient transport. Samples still require labor-intensive, manual preparation. In contrast, this is fully automated with DxNA technology.
- Considerable time is required to obtain reportable results
- Higher costs of devices and tests
- Higher power demands
Unique aspects of DxNA’s technology:
- Speed: results in 60 minutes or less
- Ease of use: the need for highly-trained technicians is eliminated
- Portability: lightweight and can be powered through a wall outlet or car battery
- Lyophilzed PCR reagents: stable without refrigeration
- Accuracy: unique, closed system rendering valid, trusted data
- Economical: less costly than current real-time PCR technologies
- Multiplexed assays test for three targets at the same time.